DIA413.04+5.62 1.38%
SPX5,686.67+82.53 1.47%
IXIC17,977.73+266.99 1.51%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·03/21/2025 17:05:38
Listen to the news

Gainers

  • Impact BioMedical (AMEX:IBO) stock increased by 98.1% to $4.12 during Friday's regular session. The company's market cap stands at $47.4 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 60.9% to $1.24.
  • Galecto (NASDAQ:GLTO) shares increased by 40.09% to $5.8. The market value of their outstanding shares is at $7.6 million. As per the press release, Q4 earnings came out 2 days ago.
  • Regencell Bioscience (NASDAQ:RGC) stock increased by 30.36% to $58.67. The market value of their outstanding shares is at $763.4 million.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) stock moved upwards by 26.71% to $23.05. The company's market cap stands at $128.8 million. As per the news, the Q4 earnings report came out 3 days ago.
  • CervoMed (NASDAQ:CRVO) shares moved upwards by 21.49% to $14.04. The market value of their outstanding shares is at $115.9 million. As per the press release, Q4 earnings came out 4 days ago.

Losers

  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock fell 62.1% to $0.58 during Friday's regular session. The company's market cap stands at $5.9 million.
  • TELA Bio (NASDAQ:TELA) shares decreased by 38.47% to $1.44. The market value of their outstanding shares is at $56.7 million. As per the press release, Q4 earnings came out yesterday.
  • GlucoTrack (NASDAQ:GCTK) shares declined by 31.95% to $0.28. The market value of their outstanding shares is at $2.9 million.
  • Windtree Therapeutics (NASDAQ:WINT) stock declined by 23.4% to $1.67. The market value of their outstanding shares is at $1.2 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares decreased by 16.92% to $37.17. The company's market cap stands at $226.8 million.
  • Sharps Technology (NASDAQ:STSS) shares fell 14.53% to $0.22. The company's market cap stands at $1.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.